Contact

All Stories

  1. Development and Evaluation of a Baicalin-loaded Phytosomal Transdermal Patch for Type 2 Diabetes Mellitus

    Article • Current Drug Metabolism, May 2026, Bentham Science Publishers

    Abhijit Debnath, Anjna Sharma

  2. Exosome Engineering for Targeted Therapy: Tools and Techniques

    Article • Current Drug Delivery, April 2026, Bentham Science Publishers

    Abhijit Debnath

  3. PTP1B Inhibitors for Type 2 Diabetes: From Natural Products, Synthetic Inhibitors, and Multi-Target Drug Design Strategies to Clinical Translation

    Article • Current Drug Targets, March 2026, Bentham Science Publishers

    Abhijit Debnath, AVIJIT MAZUMDER

  4. Beating Cancer's Defense: New Ways to Stop Chemotherapy Resistance

    Article • Current Pharmaceutical Design, March 2026, Bentham Science Publishers

    Abhijit Debnath, AVIJIT MAZUMDER, Mr. Siddharth .

  5. Targeting PD-1 in Squamous Cell Carcinoma: Flavonoid-based Therapeutics Unveiled through in silico and in vitro Approaches

    Article • Current Computer - Aided Drug Design, March 2026, Bentham Science Publishers

    Abhijit Debnath, Neha Sharma

  6. Discovery of Novel PTP1B Inhibitors by High-throughput Virtual Screening

    Article • Current Computer - Aided Drug Design, February 2026, Bentham Science Publishers

    Abhijit Debnath, AVIJIT MAZUMDER, Navneet Khurana, Anjna Sharma

  7. Targeting Undruggable Proteins: The siRNA Revolution Beyond Small Molecules - Advances, Challenges, and Future Prospects in Therapeutic Innovation

    Article • Current Gene Therapy, January 2026, Bentham Science Publishers

    Abhijit Debnath

  8. Antihypertensive potential of diosgenin: A comparative pharmacoinformatics study

    Article • Computers in Biology and Medicine, September 2025, Elsevier

    Abhijit Debnath

  9. Unlocking the antimalarial potential of novel steroid-tetraoxane hybrids through consensus molecular docking and molecular dynamics investigation

    Article • Scientific Reports, August 2025, Springer Science + Business Media

    Abhijit Debnath

  10. miRNA-Targeted Vaccines: A Promising Approach for Viral Attenuation and Immunogenicity Enhancement

    Article • Current Gene Therapy, August 2025, Bentham Science Publishers

    Abhijit Debnath

  11. Advancements of Glucose Monitoring Biosensor: Current State, Generations of Technological Progress and Innovation Dynamics

    Article • Current Pharmaceutical Biotechnology, August 2025, Bentham Science Publishers

    Abhijit Debnath

  12. Design, synthesis, docking, DFT, and MD simulation studies of new piperazine, 1,3,4-oxadiazole, and quinoline conjugates: A search for potent antiepileptic agents

    Article • Bioorganic Chemistry, July 2025, Elsevier

    Abhijit Debnath

  13. Challenges and Progress of Orphan Drug Development for Rare Diseases

    Article • Current Pharmaceutical Biotechnology, June 2025, Bentham Science Publishers

    Abhijit Debnath, AVIJIT MAZUMDER

  14. Discovery of novel HBV core protein inhibitors by high throughput virtual screening

    Article • Scientific Reports, April 2025, Springer Science + Business Media

    Abhijit Debnath

  15. Integration of In-vivo screening, molecular docking, and molecular dynamics simulations for studying the antiepileptic potential of newly synthesized 5-naphthalen-1-yl-5,10-dihydro-1H-pyrimido[4,5-b]quinoline-2,4-diones in optimized reaction conditions...

    Article • Journal of Molecular Structure, March 2025, Elsevier

    DR. RAJNISH KUMAR, Abhijit Debnath

  16. Clinical Progress of Targeted Therapy for Breast Cancer: A Comprehensive Review

    Article • Current Cancer Drug Targets, March 2025, Bentham Science Publishers

    Abhijit Debnath

  17. Experimental, quantum chemical spectroscopic investigation, topological, molecular docking/dynamics and biological assessment studies of 2,6-Dihydroxy-4-methyl quinoline

    Article • Journal of Molecular Structure, February 2025, Elsevier

    Abhijit Debnath

  18. Identification of novel cyclin-dependent kinase 4/6 inhibitors from marine natural products

    Article • PLOS One, January 2025, PLOS

    Abhijit Debnath

  19. Quest for discovering novel CDK12 inhibitor

    Article • Journal of Receptors and Signal Transduction, December 2024, Taylor & Francis

    Abhijit Debnath

  20. New CDK 4/6 Cancer Inhibitors via Virtual Screening

    Article • Letters in Drug Design & Discovery, December 2024, Bentham Science Publishers

    Abhijit Debnath

  21. A Deep Dive into PDE5 Inhibition: Innovative Discoveries via Virtual Screening

    Article • Letters in Drug Design & Discovery, December 2024, Bentham Science Publishers

    Abhijit Debnath

  22. Discovery of novel CDK4/6 inhibitors from fungal secondary metabolites

    Article • International Journal of Biological Macromolecules, December 2024, Elsevier

    Abhijit Debnath

  23. Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes

    Article • All Life, October 2024, Taylor & Francis

    Abhijit Debnath

  24. Role of PD‐1 in Skin Cancer: Molecular Mechanism, Clinical Applications, and Resistance

    Article • Chemical Biology & Drug Design, September 2024, Wiley

    Abhijit Debnath

  25. Discovery of new HDAC6 inhibitors for cancer

    Article • Letters in Drug Design & Discovery, May 2024, Bentham Science Publishers

    Abhijit Debnath, AVIJIT MAZUMDER

  26. "Virtual Screening for Novel SGLT2 Inhibitors in Type 2 Diabetes"

    Article • Current Drug Discovery Technologies, December 2023, Bentham Science Publishers

    Abhijit Debnath

  27. Quest for Discovering Novel CDK12 Inhibitor by Leveraging High-Throughput Virtual Screening

    Article • September 2023, Research Square

    Abhijit Debnath

  28. A Brief Study on Drug Repurposing: New Way of Boosting Drug Discovery

    Article • Letters in Drug Design & Discovery, March 2023, Bentham Science Publishers

    Abhijit Debnath, Manisha Patel

  29. A BRIEF DESCRIPTION OF COVID-19 PULMONARY VIRAL INFECTION AND REPURPOSING OF DRUGS FOR ITS TREATMENT

    Article • International Journal of Applied Pharmaceutics, September 2022, Innovare Academic Sciences Pvt Ltd

    Abhijit Debnath

  30. In-silico and in-vivo evaluation of comparative enhanced neurogenic performance by energy drinks

    Article • International Journal of Health Sciences, July 2022, Universidad Tecnica de Manabi

    Abhijit Debnath

  31. PD 1: A Trending Target in Anti-cancer Research

    Article • Biointerface Research in Applied Chemistry, June 2022, AMG Transcend Association

    Abhijit Debnath

  32. Development, optimization, evaluation of inhalable solid sedds to cure pulmonary arterial hypertension (PAH)

    Article • Journal of Genetic Syndromes & Gene Therapy, January 2017, OMICS Publishing Group

    Abhijit Debnath